News

Biogen to acquire Apellis in $5.6bn deal

Apr 9, 2026 | News, Sales

The deal will enhance Biogen’s growth portfolio in immunology and rare disease

Gilead to acquire Tubulis for up to $5bn

Apr 8, 2026 | News, Sales

The acquisition builds on Gilead’s oncology pipeline, focused on addressing areas of high unmet need

Lilly’s Foundayo approved by US FDA as oral GLP-1 for weight loss

Apr 7, 2026 | News, Regulatory

Taken at any time of the day, the oral GLP-1 is the only pill to have no food or water restrictions

Roche opens new Swiss Institute of Human Biology research facility

Apr 2, 2026 | News, Research

The new building is part of a 1.5bn euro site investment

Novartis to acquire Excellergy in deal worth up to $2bn

Apr 1, 2026 | News, Sales

Exl-111, a potential treatment included in the deal, is a central factor in many allergic diseases

Novo Nordisk’s Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes

Mar 31, 2026 | News, Regulatory

The insulin is designed as an alternative to daily basal insulin

Sandoz partners with Samsung Bioepis to develop up to five biosimilars

Mar 31, 2026 | News, Research

The agreement will expand the pipeline and builds on an existing partnership

Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment

Mar 30, 2026 | News, Research

Quotient’s somatic genomics platform technology will be used to develop the treatment

Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development

Mar 27, 2026 | News, Healthcare

The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients

BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma

Mar 26, 2026 | News, Regulatory

This type of cancer is the most common one diagnosed in teenagers

Eisai and Biogen’s new data shows Alzheimer’s patients choose to stay on Leqembi long-term

Mar 25, 2026 | News, Research

The findings were presented at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases in Denmark

Scotland becomes first part of UK to screen all newborn babies for SMA

Mar 24, 2026 | News, Healthcare

The screening is part of a two-year evaluation funded by the Scottish government and Novartis

Biogen to acquire Apellis in $5.6bn deal

Gilead to acquire Tubulis for up to $5bn

Lilly’s Foundayo approved by US FDA as oral GLP-1 for weight loss

Roche opens new Swiss Institute of Human Biology research facility

Novartis to acquire Excellergy in deal worth up to $2bn

Novo Nordisk’s Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes

Sandoz partners with Samsung Bioepis to develop up to five biosimilars

Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment

BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma

Eisai and Biogen’s new data shows Alzheimer’s patients choose to stay on Leqembi long-term

Scotland becomes first part of UK to screen all newborn babies for SMA

Latest content

Latest intelligence

Quick links